These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38824869)

  • 1. Type III interferons in innate and adaptive immunity in the respiratory tract.
    Piperakis A; Galani IE; Andreakos E
    Curr Opin Immunol; 2024 Apr; 87():102430. PubMed ID: 38824869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces.
    Stanifer ML; Guo C; Doldan P; Boulant S
    Front Immunol; 2020; 11():608645. PubMed ID: 33362795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lambda interferons in immunity and autoimmunity.
    Vlachiotis S; Andreakos E
    J Autoimmun; 2019 Nov; 104():102319. PubMed ID: 31481283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon lambda in inflammation and autoimmune rheumatic diseases.
    Goel RR; Kotenko SV; Kaplan MJ
    Nat Rev Rheumatol; 2021 Jun; 17(6):349-362. PubMed ID: 33907323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lambda interferons come to light: dual function cytokines mediating antiviral immunity and damage control.
    Andreakos E; Zanoni I; Galani IE
    Curr Opin Immunol; 2019 Feb; 56():67-75. PubMed ID: 30399529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The unique regulation and functions of type III interferons in antiviral immunity.
    Odendall C; Kagan JC
    Curr Opin Virol; 2015 Jun; 12():47-52. PubMed ID: 25771505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type III Interferons in Antiviral Defenses at Barrier Surfaces.
    Wells AI; Coyne CB
    Trends Immunol; 2018 Oct; 39(10):848-858. PubMed ID: 30219309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type III IFNs: Beyond antiviral protection.
    Kotenko SV; Rivera A; Parker D; Durbin JE
    Semin Immunol; 2019 Jun; 43():101303. PubMed ID: 31771761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shared and Distinct Functions of Type I and Type III Interferons.
    Lazear HM; Schoggins JW; Diamond MS
    Immunity; 2019 Apr; 50(4):907-923. PubMed ID: 30995506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond Good and Evil: Molecular Mechanisms of Type I and III IFN Functions.
    Dowling JW; Forero A
    J Immunol; 2022 Jan; 208(2):247-256. PubMed ID: 35017214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective Potentials of Type III Interferons in COVID-19 Patients: Lessons from Differential Properties of Type I- and III Interferons.
    Jafarzadeh A; Nemati M; Saha B; Bansode YD; Jafarzadeh S
    Viral Immunol; 2021 Jun; 34(5):307-320. PubMed ID: 33147113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of type III interferons to antiviral immunity: location, location, location.
    Kotenko SV; Durbin JE
    J Biol Chem; 2017 May; 292(18):7295-7303. PubMed ID: 28289095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I and III IFNs produced by the nasal epithelia and dimmed inflammation are features of alpacas resolving MERS-CoV infection.
    Te N; Rodon J; Ballester M; Pérez M; Pailler-García L; Segalés J; Vergara-Alert J; Bensaid A
    PLoS Pathog; 2021 May; 17(5):e1009229. PubMed ID: 34029358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type III interferon is a critical regulator of innate antifungal immunity.
    Espinosa V; Dutta O; McElrath C; Du P; Chang YJ; Cicciarelli B; Pitler A; Whitehead I; Obar JJ; Durbin JE; Kotenko SV; Rivera A
    Sci Immunol; 2017 Oct; 2(16):. PubMed ID: 28986419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus.
    Chyuan IT; Tzeng HT; Chen JY
    Cells; 2019 Aug; 8(9):. PubMed ID: 31450787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type III Interferons in Viral Infection and Antiviral Immunity.
    Zhou JH; Wang YN; Chang QY; Ma P; Hu Y; Cao X
    Cell Physiol Biochem; 2018; 51(1):173-185. PubMed ID: 30439714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct Effects of Type I and III Interferons on Enteric Viruses.
    Ingle H; Peterson ST; Baldridge MT
    Viruses; 2018 Jan; 10(1):. PubMed ID: 29361691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III Interferons.
    Forero A; Ozarkar S; Li H; Lee CH; Hemann EA; Nadjsombati MS; Hendricks MR; So L; Green R; Roy CN; Sarkar SN; von Moltke J; Anderson SK; Gale M; Savan R
    Immunity; 2019 Sep; 51(3):451-464.e6. PubMed ID: 31471108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-λs: Front-Line Guardians of Immunity and Homeostasis in the Respiratory Tract.
    Andreakos E; Salagianni M; Galani IE; Koltsida O
    Front Immunol; 2017; 8():1232. PubMed ID: 29033947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functions of IFNλs in Anti-Bacterial Immunity at Mucosal Barriers.
    Alphonse N; Dickenson RE; Alrehaili A; Odendall C
    Front Immunol; 2022; 13():857639. PubMed ID: 35663961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.